Virtual Reality for Post-Stroke Gait Rehabilitation
iWalk in VR: Integration of Virtual Reality-based Locomotor Rehabilitation in Clinical Care
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this clinical trial is to: (1) implement and test the feasibility of a new VR-ODT intervention offered as part of usual therapy time of patients with a sub-acute stoke; (2) explore the acceptability of the intervention from the perspective of clinicians and patients and; (3) implement measures to optimize the uptake and sustainability of the intervention within the clinical setting. Participants will engage in a personalized VR-ODT training for 4 weeks (2X 1hr/week) targeting six well-established community walking demands related to (1) walking speed and (2) distance; (3) postural transitions; (4) obstacle avoidance; (5) dual-task walking and; (6) a combination of demands 1-5. For each demand, patients will progress through levels of increasing difficulty according to personalized goals and success criteria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2025
CompletedFirst Posted
Study publicly available on registry
October 1, 2025
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
March 20, 2026
February 1, 2026
9 months
September 9, 2025
March 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (16)
Feasibility: adherence to intervention - number of completed sessions
Training logbook filled by clinicians
2x/week over the 4-week intervention
Feasibility: presence of adverse or undesirable effects during the intervention
Assesses by systematically collecting any occurrence of adverse/unwanted events (falls, injuries, fatigue, etc). Collected with open-ended questions.
Post-Intervention (week4)
Feasibility: Number of participants recruited in each program
Number of early discharged participants vs. outpatient program participants
Pre-intervention (week0)
Feasibility: Characteristics of stroke participants: age
Collected via medical charts
Pre-intervention (week 0)
Feasibility: Characteristics of stroke participants: sex
Collected via medical charts
Pre-intervention (week 0)
Feasibility: Characteristics of stroke participants: gender
Collected via medical charts
Pre-intervention (week 0)
Feasibility: Characteristics of stroke participants: walking capacity
Collected via medical charts. According to physiotherapy evaluations, walking capacity is characterized as severely, moderately or mildly affected.
Pre-intervention (week 0)
Feasibility: Characteristics of stroke participants: cognitive function
Collected via medical charts. According to occupationnal therapy evaluations, cognitive fonction is characterised as severely affected, moderately affected, mildly affected, or intact.
Pre-intervention (week 0)
Feasibility: Characteristics of stroke participants: visual-perceptual function
Collected via medical charts. According to occupationnal therapy evaluations, visual-perceptual function is characterised as severely affected, moderately affected, mildly affected, or intact.
Pre-intervention (week 0)
Feasibility: Characteristics of clinicians
collected via paper-based questionnaire
Pre-intervention (week0)
Feasibility: Number of eligible vs. referred participants
Assessed using the number of participants referred to the study in comparison to the list of admitted patients in the targeted stroke programs.
Post-intervention (week4)
Feasibility: Perceived mental and physical demands
Collected using the NASA Tax Load Index. It assesses work load on five 7-point scales. Increments of high, medium and low estimates for each point result in 21 gradations on the scales.
Post-Intervention (week4)
Feasibility: Sense of presence
Collected with the Single-Item Presence Questionnaire, a brief measure used to assess a participant's sense of presence in a virtual environment. It consists of one question rated on a 7-point Likert scale, ranging from 1 ("not at all") to 7 ("completely").
Post-Intervention (week4)
Feasibility: Presence of cybersickness
Collected via the Simulator Sickness Questionnaire, used for assessing symptoms of motion or simulator sickness following exposure to virtual environments. It includes 16 symptoms rated on a 4-point scale from 0 ("none") to 3 ("severe"), covering nausea, oculomotor discomfort, and disorientation.
Post-Intervention (week4)
Acceptability of the intervention
Assesses using the Technology Acceptance Model based Questionnaire (Tam-Q) based on the technology acceptance model, in which participants (patients and cliniciens) will rate their perception on each dimension using a visual analog scale ranging from 0-56, with higher score representing higher acceptance to the intervention.
Post-intervention (Week4)
Acceptability: Overall experience
Investigated through open-ended questions
Post-Intervention (Week4)
Study Arms (1)
VR training
EXPERIMENTALParticipants will engage in a 4-week VR intervention that comprises of 1-hour training sessions, 2 times/week.
Interventions
The VR intervention involves the intensive practice of community ambulation skills. The training sessions will be performed in a virtual environment. During the intervention, stroke participants will be invited to practice different dimensions of community ambulation, such as postural transitions, avoiding other pedestrians, dual-task walking, etc.
Eligibility Criteria
You may qualify if:
- Eligible patients with stroke referred by clinicians of the inpatient and outpatient stroke rehabilitation programs at the Jewish Rehabilitation Hospital (CISSS Laval) for mobility problems over a period of 6 months will be recruited. They will:
- be aged between 40 and 74 years;
- have normal/corrected visual and auditory acuity present;
- present a first-ever supratentorial unilateral stroke of 1-24 weeks duration;
- present the ability to walk independently with/without walking aids for at least 1 min at a speed of 0.4-0.9 m/s;
- present intact or mildly affected cognitive function (MoCA scores ≥ 22/30);
- present intact to moderately affected visual- perceptual function (positive scores on a max. of 3/6 tasks on the Behavioural Inattention Test).
You may not qualify if:
- Subjects with comorbidities interfering with walking
- Subjects with comorbidities interfering with visual perception
- Subjects without medical clearance for exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McGill Universitylead
- Jewish Rehabilitation Hospitalcollaborator
Study Sites (1)
Jewish Rehabilitation Hospital
Laval, Quebec, H7V1R2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anouk Lamontagne, PhD
McGill University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 9, 2025
First Posted
October 1, 2025
Study Start
February 1, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
December 1, 2027
Last Updated
March 20, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will be available within 6 months of study completion
- Access Criteria
- De-identified data will be deposited in a REDCap database and made available to collaborators. Data may also be made available to other researchers via an institutional data repository that will allow adhering to FAIR principles.
De-identified individual participant data for all primary and secondary outcome measure will be made available.